Search results

Commission Directive 86/530/EEC of 28 October 1986 amending the Annex to Council Directive 82/471/EEC concerning certain products used in animal nutrition

OJ L 312, 07/11/1986, p. 39–41 (ES, DA, DE, EL, EN, FR, IT, NL, PT)
This document has been published in a special edition(s) ( FI, SV, CS, ET, LV, LT, HU, MT, PL, SK, SL, BG, RO)

OJ L 312, 07/11/1986, p. 39–41

Legal status of the document No longer in force

CELEX number:: 31986L0530
Languages:: ES, DA, DE, EL, EN, FR, IT, NL, PT
Form:: Directive

Author:: European Commission
Date of document:: 28/10/1986
Number of pages:: 3

pdf
html

Case T-127/25: Action brought on 20 February 2025 – Novavax v EUIPO – Brill International (MATRIX-V)

OJ C, C/2025/2406, 28.4.2025, ELI: http://data.europa.eu/eli/C/2025/2406/oj (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

OJ C, C/2025/2406, 28.4.2025, ELI: http://data.europa.eu/eli/C/2025/2406/oj

CELEX number:: 62025TN0127
Languages:: BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV
Form:: Judicial information

Author:: General Court
Date of document:: 20/02/2025

pdf
html

Case T-126/25: Action brought on 20 February 2025 – Novavax v EUIPO – Brill International (MATRIX-A)

OJ C, C/2025/2405, 28.4.2025, ELI: http://data.europa.eu/eli/C/2025/2405/oj (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

OJ C, C/2025/2405, 28.4.2025, ELI: http://data.europa.eu/eli/C/2025/2405/oj

CELEX number:: 62025TN0126
Languages:: BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV
Form:: Judicial information

Author:: General Court
Date of document:: 20/02/2025

pdf
html

Case T-129/25: Action brought on 20 February 2025 – Novavax v EUIPO – Brill International (MATRIX-M)

OJ C, C/2025/2408, 28.4.2025, ELI: http://data.europa.eu/eli/C/2025/2408/oj (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

OJ C, C/2025/2408, 28.4.2025, ELI: http://data.europa.eu/eli/C/2025/2408/oj

CELEX number:: 62025TN0129
Languages:: BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV
Form:: Judicial information

Author:: General Court
Date of document:: 20/02/2025

pdf
html

Case T-128/25: Action brought on 20 February 2025 – Novavax v EUIPO – Brill International (MATRIX-C)

OJ C, C/2025/2407, 28.4.2025, ELI: http://data.europa.eu/eli/C/2025/2407/oj (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

OJ C, C/2025/2407, 28.4.2025, ELI: http://data.europa.eu/eli/C/2025/2407/oj

CELEX number:: 62025TN0128
Languages:: BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV
Form:: Judicial information

Author:: General Court
Date of document:: 20/02/2025

pdf
html

Case C-210/13: Order of the Court (Eighth Chamber) of 14 November 2013 (request for a preliminary ruling from the High Court of Justice (Chancery Division) — United Kingdom) — Glaxosmithkline Biologicals SA, Glaxosmithkline Biologicals, Niederlassung der Smithkline Beecham Pharma GmbH & Co. KG v Comptroller-General of Patents, Designs and Trade Marks (Medicinal products for human use — Supplementary protection certificate — Regulation (EC) No 469/2009 — Concepts of ‘active ingredient’ and ‘combination of active ingredients’ — Adjuvant)

OJ C 102, 07/04/2014, p. 10–11 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

OJ C 102, 07/04/2014, p. 10–11

CELEX number:: 62013CB0210
Languages:: BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV
Form:: Judicial information

Author:: Court of Justice
Date of document:: 14/11/2013
Number of pages:: 1

pdf
html

Case C-210/13: Reference for a preliminary ruling from High Court of Justice (Chancery Division) (United Kingdom) made on 18 April 2013 — Glaxosmithline Biologicals SA, Glaxosmithkline Biologicals, Niederlassung der Smithkline Beecham Pharma GmbH & Co. KG v Comptroller-General of Patents, Designs and Trade Marks

OJ C 189, 29/06/2013, p. 8–8 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

OJ C 189, 29/06/2013, p. 8–8

CELEX number:: 62013CN0210
Languages:: BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV
Form:: Judicial information

Author:: Court of Justice
Date of document:: 18/04/2013
Number of pages:: 1

pdf
html

2012/209/EU: Commission Implementing Decision of 20 April 2012 concerning the application of the control and movement provisions of Council Directive 2008/118/EC to certain additives, in accordance with Article 20(2) of Council Directive 2003/96/EC (notified under document C(2012) 2484)

OJ L 110, 24/04/2012, p. 41–41 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

OJ L 110, 24/04/2012, p. 41–41

Legal status of the document In force

CELEX number:: 32012D0209
Languages:: BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV
Form:: Implementing decision

Author:: European Commission
Date of document:: 20/04/2012
Number of pages:: 1

pdf
html

2011/545/EU: Commission Implementing Decision of 16 September 2011 concerning the application of the control and movement provisions of Council Directive 2008/118/EC to products falling within CN code 3811 , in accordance with Article 20(2) of Council Directive 2003/96/EC (notified under document C(2011) 6423)

OJ L 241, 17/09/2011, p. 33–33 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
This document has been published in a special edition(s) ( HR)

OJ L 241, 17/09/2011, p. 33–33

Legal status of the document No longer in force

CELEX number:: 32011D0545
Languages:: BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV
Form:: Implementing decision

Author:: European Commission
Date of document:: 16/09/2011
Number of pages:: 1

pdf
html

Non-opposition to a notified concentration (Case M.10381 — One Rock Capital/The Eastman Tire Additives business of Eastman Chemical Company) (Text with EEA relevance) 2021/C 384/01

C/2021/6576

OJ C 384, 22/09/2021, p. 1–1 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

OJ C 384, 22/09/2021, p. 1–1

CELEX number:: 52021M10381(01)
Languages:: BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV
Form:: Notice

Author:: European Commission, Directorate-General for Competition
Date of document:: 01/09/2021
Number of pages:: 1

pdf
html

Choose the experimental features you want to try